[Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction--second edition].
Hosoya
Tatsuo
T
Okada
Hirokazu
H
Horio
Masaru
M
Ohno
Iwao
I
Tamura
Shozo
S
Sugimoto
Hideharu
H
Tsushima
Yoshito
Y
Hayashi
Hiromitsu
H
Fukuda
Kunihiko
K
Korogi
Yukunori
Y
Yoshifumi
Narumi
N
D000075202:Contraindications; D003287:Contrast Media / Q000008:administration & dosage* / Q000009:adverse effects; D005682:Gadolinium / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging; D054989:Nephrogenic Fibrosing Dermopathy / Q000139:chemically induced / Q000517:prevention & control
D003287:Contrast Media; D005682:Gadolinium